Back to Search
Start Over
Omalizumab in chronic inducible urticaria: A real-life study of efficacy, safety, predictors of treatment outcome and time to response.
- Source :
-
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology [Clin Exp Allergy] 2021 May; Vol. 51 (5), pp. 730-734. Date of Electronic Publication: 2021 Feb 08. - Publication Year :
- 2021
Details
- Language :
- English
- ISSN :
- 1365-2222
- Volume :
- 51
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
- Publication Type :
- Report
- Accession number :
- 33522024
- Full Text :
- https://doi.org/10.1111/cea.13838